Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

Perceptive Advisors

Venture Capital, Private Equity · Founded 2018 · New York City, United States

Focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare

158 portfolio companies Venture Capital, Private Equity · $22B invested · 285 investments · Investor rank #105 · Last investment 6/2026
Portfolio companies ↑ 63% 5y
158
Decacorns
3
Thoroughbreds ↑ 40% 5y
26
Exits

Perceptive Advisors’s biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Perceptive Advisors’s transaction record.

$2.0B IPO · 2019
Entered Series B+Now $17BHealth
IPO · 2020
Entered Series B+Now $12BHealth
$391M IPO · 2018
Entered Series B+Now $10BHealth
$707M IPO · 2021
Entered Series B+Now $8.9BHealth
$8.7B acquisition · 2023
Now $6.9BHealth
$130M IPO · 2016
Now $7.7BHealth
$350M IPO · 2018
Now $6.1BHealth
$494M IPO · 2025
Entered Series B+Now $4.3BHealth
$311M IPO · 2023
Entered Series B+Now $3.7BHealth
$1.7B IPO · 2020
Entered Series B+Now $3.7BHealth
$3.5B IPO · 2021
Entered Series B+Now $226MHealth
IPO · 2019
Entered Series B+Now $3.3BHealth
Portfolio analysis

Where Perceptive Advisors's portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 158 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA136
  2. UK8
  3. Canada3
  4. China3
  5. France2
  6. Belgium1
  7. Denmark1
  8. Germany1
  9. India1
  10. Israel1
  11. Switzerland1
By sectorCount
  1. Health156
  2. Enterprise Software2
  3. Wellness Beauty2
  4. Food1
  5. Robotics1
  6. Transportation1
By stage enteredCount
  1. Series B+104
  2. Series A29
  3. Seed2
By growth stageCount
  1. Late Growth121
  2. Breakout Stage35
  3. Early Growth2
Portfolio market map

Inside Perceptive Advisors's portfolio.

The 60 highest-funded portfolio companies, of 158 tracked.

Freenome
Health · Unicorn
$1.1B
Caris Life Sciences
Health · Unicorn
$4.3B
Cue
Health
Zymergen
Health
$226M
I-Mab Biopharma
Health
$215M
GeneDx Inc
Health · Unicorn
$1.9B
Insightec
Health · Unicorn
$1.3B
BridgeBio
Health · Decacorn
$17B
Bicycle Therapeutics
Health
Cerevel Therapeutics
Health · Unicorn
$6.9B
Imperative Care
Health · Unicorn
$1.3B
Impulse Dynamics
Health
$632M
Sema4
Health · Unicorn
$2.0B
Outset Medical
Health
$23M
Kardigan
Health · Unicorn
$1.6B
Relay Therapeutics
Health · Unicorn
$3.7B
Allogene Therapeutics
Health
$429M
Avidity Biosciences
Health · Decacorn
$12B
Saama Technologies
Health
$160M
Solid Biosciences
Health
$498M
Immatics biotechnologies
Health
$811M
DNAnexus
Health
$600M
Crinetics Pharmaceuticals
Health · Decacorn
$10B
Synthego
Health
$800M
Oruka Therapeutics
Health
SpringWorks Therapeutics
Health · Unicorn
$3.3B
Omada Health
Health · Unicorn
$1.2B
Galecto | Damora Therapeutics
Health · Unicorn
$2.1B
Enjoy
Transportation · Unicorn
$1.2B
RayzeBio
Health · Unicorn
$3.7B
Talkiatry
Health · Unicorn
$1.4B
COMPASS Pathways
Health · Unicorn
$1.3B
Ocular Therapeutix
Health · Unicorn
$1.4B
Avalyn Pharma
Health · Unicorn
$1.1B
Thrive Earlier Detection
Health · Unicorn
$2.2B
Day One Biopharmaceuticals
Health · Unicorn
$1.8B
Affinivax
Health · Unicorn
$2.1B
Capstan Therapeutics
Health · Unicorn
$2.1B
Pyxis Oncology
Health
$127M
Poseida Therapeutics
Health
$778M
PROCEPT BioRobotics
Health
$926M
Viridian Therapeutics
Health · Unicorn
$1.4B
Zenas BioPharma
Health · Unicorn
$1.4B
Sonendo
Health
$10M
Neuron23
Health
$500M
LianBio
Health
Orchard Therapeutics
Health
$303M
Alto Neuroscience
Health
$830M
Kindbody
Health · Unicorn
$1.8B
Nautilus
Health
$156M
Endeavor BioMedicines
Health
$530M
Sionna Therapeutics
Health · Unicorn
$2.0B
Cogent Biosciences
Health · Unicorn
$6.1B
Beta Bionics
Health
$204M
Twin Health
Health
$950M
Atea Pharmaceuticals
Health
$135M
Crossover Health Management Services
Health
$672M
Taysha Gene Therapies
Health · Unicorn
$1.5B
Kronos Bio
Health
NiKang Therapeutics
Health
$382M
Portfolio founders

Where Perceptive Advisors's portfolio founders come from.

134 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States101
  2. United Kingdom7
  3. Australia3
  4. China3
  5. Denmark3
  6. Germany3
  7. France2
  8. India2
  9. Israel2
  10. Sweden2
UniversityCount
  1. Massachusetts Institute of Technology10
  2. Stanford University8
  3. University of California, Berkeley7
  4. Columbia University5
  5. Harvard Business School5
  6. Harvard Medical School5
  7. Harvard University4
  8. Brown University3
  9. Case Western Reserve University3
  10. Dartmouth College3
Previous companyCount
  1. Harvard Medical School4
  2. Sanofi Aventis4
  3. Amblyotech3
  4. Apple3
  5. Bristol-Myers Squibb3
  6. Johnson & Johnson3
  7. Lehman Brothers3
  8. Massachusetts General Hospital3
  9. Merck & Co.3
  10. MyoKardia3
Every figure on this page is sourced live from the Dealroom next-gen API. Sections v1 shows that the API does not yet expose — shareholding-based holdings, Power-Law rankings & vintage time-series, entity-filtered news, and market sentiment — are omitted here rather than sourced elsewhere.